Matches in Wikidata for { <http://www.wikidata.org/entity/Q92758001> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q92758001 description "artículu científicu espublizáu en mayu de 2019" @default.
- Q92758001 description "scientific article published on 14 May 2019" @default.
- Q92758001 description "wetenschappelijk artikel" @default.
- Q92758001 description "наукова стаття, опублікована 14 травня 2019" @default.
- Q92758001 name "MCL1 inhibition enhances the therapeutic effect of MEK inhibitors in KRAS-mutant lung adenocarcinoma cells" @default.
- Q92758001 name "MCL1 inhibition enhances the therapeutic effect of MEK inhibitors in KRAS-mutant lung adenocarcinoma cells" @default.
- Q92758001 type Item @default.
- Q92758001 label "MCL1 inhibition enhances the therapeutic effect of MEK inhibitors in KRAS-mutant lung adenocarcinoma cells" @default.
- Q92758001 label "MCL1 inhibition enhances the therapeutic effect of MEK inhibitors in KRAS-mutant lung adenocarcinoma cells" @default.
- Q92758001 prefLabel "MCL1 inhibition enhances the therapeutic effect of MEK inhibitors in KRAS-mutant lung adenocarcinoma cells" @default.
- Q92758001 prefLabel "MCL1 inhibition enhances the therapeutic effect of MEK inhibitors in KRAS-mutant lung adenocarcinoma cells" @default.
- Q92758001 P1433 Q92758001-627BCCC6-37C8-4F4A-9007-C4057ED9CB2B @default.
- Q92758001 P1476 Q92758001-442F9B80-3D61-4ED4-9135-F59547303A18 @default.
- Q92758001 P2093 Q92758001-26A09880-4381-479D-8B4A-B637AF69E327 @default.
- Q92758001 P2093 Q92758001-3085E62C-BFEB-4974-AB3D-9B4F53A081BB @default.
- Q92758001 P2093 Q92758001-4963966C-B3CB-4641-86F7-72D3E457CC2B @default.
- Q92758001 P2093 Q92758001-6BA16A96-4011-440F-BEFE-81CB94CAFBAA @default.
- Q92758001 P2093 Q92758001-860C791A-4903-4BCC-9AA2-D5BB45ECACAA @default.
- Q92758001 P2093 Q92758001-B2B8D9C7-48DC-468D-8E6E-953E5693ABBB @default.
- Q92758001 P2093 Q92758001-CCD99C42-70F8-42B6-9427-C478C7355A89 @default.
- Q92758001 P2093 Q92758001-E44E7B15-1E28-403E-BACC-4934A3FA34B4 @default.
- Q92758001 P2093 Q92758001-E6966CC1-4E01-4F3B-A0D1-85263060CAAF @default.
- Q92758001 P2860 Q92758001-4C2CEAF1-0C82-4322-9BBD-A27A4EB584BD @default.
- Q92758001 P304 Q92758001-DCA6BC12-F272-46A5-91B3-FDB5C3F448ED @default.
- Q92758001 P31 Q92758001-EAA43501-AB05-4BBE-BCCA-1A0B076BF231 @default.
- Q92758001 P356 Q92758001-C15EB562-9298-4646-96DE-7D90C6C1C208 @default.
- Q92758001 P478 Q92758001-AA2A8022-5F41-4895-BD74-274EA438AA11 @default.
- Q92758001 P50 Q92758001-F33E9991-FEC1-4382-AD90-44256D144200 @default.
- Q92758001 P577 Q92758001-42B67C66-DFC5-480B-9640-B88FA4D0F29A @default.
- Q92758001 P698 Q92758001-725E175E-5B18-464F-926C-4CA2C3C8B1CA @default.
- Q92758001 P356 J.LUNGCAN.2019.05.014 @default.
- Q92758001 P698 31200834 @default.
- Q92758001 P1433 Q641464 @default.
- Q92758001 P1476 "MCL1 inhibition enhances the therapeutic effect of MEK inhibitors in KRAS-mutant lung adenocarcinoma cells" @default.
- Q92758001 P2093 "Atsushi Watanabe" @default.
- Q92758001 P2093 "Hiroki Takahashi" @default.
- Q92758001 P2093 "Makoto Tada" @default.
- Q92758001 P2093 "Masahiro Miyajima" @default.
- Q92758001 P2093 "Miki Yamaguchi" @default.
- Q92758001 P2093 "Sachie Hirai" @default.
- Q92758001 P2093 "Toshiro Niki" @default.
- Q92758001 P2093 "Toshiyuki Sumi" @default.
- Q92758001 P2093 "Yusuke Tanaka" @default.
- Q92758001 P2860 Q28393146 @default.
- Q92758001 P304 "88-95" @default.
- Q92758001 P31 Q13442814 @default.
- Q92758001 P356 "10.1016/J.LUNGCAN.2019.05.014" @default.
- Q92758001 P478 "133" @default.
- Q92758001 P50 Q88571071 @default.
- Q92758001 P577 "2019-05-14T00:00:00Z" @default.
- Q92758001 P698 "31200834" @default.